Bruno Domon

Title: Bruno Domon: Innovator in Cancer Diagnosis

Introduction

Bruno Domon is a notable inventor based in Luxembourg, LU. He has made significant contributions to the field of cancer diagnosis through his innovative research and development. His work focuses on the identification of biomarkers that can aid in the early detection and prognosis of bladder cancer.

Latest Patents

Bruno Domon holds a patent related to bladder cancer biomarker proteins. This invention encompasses a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis. It also includes an artificial protein comprising these signature peptides and a nucleic acid construct encoding for such an artificial protein. Furthermore, the invention outlines a method for cancer diagnosis and/or prognosis that involves analyzing at least 10 proteins in a urine sample from a subject. Additionally, it features an immunoassay product that comprises antibodies for detecting these proteins. He has 1 patent to his name.

Career Highlights

Throughout his career, Bruno Domon has worked with several prominent organizations. He has been associated with Polyquant GmbH and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His work in these companies has contributed to advancements in cancer research and diagnostics.

Collaborations

Bruno has collaborated with notable professionals in his field, including Jerome Garin and Christophe Masselon. These collaborations have further enhanced his research and development efforts in cancer diagnostics.

Conclusion

Bruno Domon is a distinguished inventor whose work in bladder cancer biomarker proteins has the potential to revolutionize cancer diagnosis and prognosis. His innovative contributions continue to impact the medical field positively.